3 years ago
ReCor follows Medtronic in making case for renal denervation as FDA mulls approval decision
An analysis of three clinical trials linked the intervention to consistent reductions in blood pressure.
Read more on:
https://www.medtechdive.com/news/recor-renal-denervation-medtronic-MDT/643829/
Follow us :
